BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

590 related articles for article (PubMed ID: 30185793)

  • 21. Acute effects of Delta9-tetrahydrocannabinol and standardized cannabis extract on the auditory evoked mismatch negativity.
    Juckel G; Roser P; Nadulski T; Stadelmann AM; Gallinat J
    Schizophr Res; 2007 Dec; 97(1-3):109-17. PubMed ID: 17884351
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Assessment of Orally Administered Δ9-Tetrahydrocannabinol When Coadministered With Cannabidiol on Δ9-Tetrahydrocannabinol Pharmacokinetics and Pharmacodynamics in Healthy Adults: A Randomized Clinical Trial.
    Zamarripa CA; Spindle TR; Surujunarain R; Weerts EM; Bansal S; Unadkat JD; Paine MF; Vandrey R
    JAMA Netw Open; 2023 Feb; 6(2):e2254752. PubMed ID: 36780161
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Acute and chronic effects of cannabinoids on effort-related decision-making and reward learning: an evaluation of the cannabis 'amotivational' hypotheses.
    Lawn W; Freeman TP; Pope RA; Joye A; Harvey L; Hindocha C; Mokrysz C; Moss A; Wall MB; Bloomfield MA; Das RK; Morgan CJ; Nutt DJ; Curran HV
    Psychopharmacology (Berl); 2016 Oct; 233(19-20):3537-52. PubMed ID: 27585792
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cannabidiol Counteracts the Psychotropic Side-Effects of Δ-9-Tetrahydrocannabinol in the Ventral Hippocampus through Bidirectional Control of ERK1-2 Phosphorylation.
    Hudson R; Renard J; Norris C; Rushlow WJ; Laviolette SR
    J Neurosci; 2019 Oct; 39(44):8762-8777. PubMed ID: 31570536
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Model-based analysis on systemic availability of co-administered cannabinoids after controlled vaporised administration.
    Liu Z; Galettis P; Broyd SJ; van Hell H; Greenwood LM; de Krey P; Steigler A; Zhu X; Schneider J; Solowij N; Martin JH
    Intern Med J; 2020 Jul; 50(7):846-853. PubMed ID: 31264294
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Blunted psychotomimetic and amnestic effects of delta-9-tetrahydrocannabinol in frequent users of cannabis.
    D'Souza DC; Ranganathan M; Braley G; Gueorguieva R; Zimolo Z; Cooper T; Perry E; Krystal J
    Neuropsychopharmacology; 2008 Sep; 33(10):2505-16. PubMed ID: 18185500
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The acute effects of cannabis, with and without cannabidiol, on attentional bias to cannabis related cues: a randomised, double-blind, placebo-controlled, cross-over study.
    Hall D; Lawn W; Ofori S; Trinci K; Borissova A; Mokrysz C; Petrilli K; Bloomfield MAP; Wall MB; Freeman TP; Curran HV
    Psychopharmacology (Berl); 2024 Jun; 241(6):1125-1134. PubMed ID: 38416223
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Distinct effects of {delta}9-tetrahydrocannabinol and cannabidiol on neural activation during emotional processing.
    Fusar-Poli P; Crippa JA; Bhattacharyya S; Borgwardt SJ; Allen P; Martin-Santos R; Seal M; Surguladze SA; O'Carrol C; Atakan Z; Zuardi AW; McGuire PK
    Arch Gen Psychiatry; 2009 Jan; 66(1):95-105. PubMed ID: 19124693
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effect of Cannabidiol and Δ9-Tetrahydrocannabinol on Driving Performance: A Randomized Clinical Trial.
    Arkell TR; Vinckenbosch F; Kevin RC; Theunissen EL; McGregor IS; Ramaekers JG
    JAMA; 2020 Dec; 324(21):2177-2186. PubMed ID: 33258890
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effects of Cannabidiol and Delta-9-Tetrahydrocannabinol on Plasma Endocannabinoid Levels in Healthy Volunteers: A Randomized Double-Blind Four-Arm Crossover Study.
    Chester LA; Englund A; Chesney E; Oliver D; Wilson J; Sovi S; Dickens AM; Oresic M; Linderman T; Hodsoll J; Minichino A; Strang J; Murray RM; Freeman TP; McGuire P
    Cannabis Cannabinoid Res; 2024 Feb; 9(1):188-198. PubMed ID: 36493386
    [No Abstract]   [Full Text] [Related]  

  • 31. Effects of daily Δ
    Withey SL; Kangas BD; Charles S; Gumbert AB; Eisold JE; George SR; Bergman J; Madras BK
    Drug Alcohol Depend; 2021 Apr; 221():108629. PubMed ID: 33640678
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The effect of five day dosing with THCV on THC-induced cognitive, psychological and physiological effects in healthy male human volunteers: A placebo-controlled, double-blind, crossover pilot trial.
    Englund A; Atakan Z; Kralj A; Tunstall N; Murray R; Morrison P
    J Psychopharmacol; 2016 Feb; 30(2):140-51. PubMed ID: 26577065
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A Critical Review of the Role of the Cannabinoid Compounds Δ
    Jones É; Vlachou S
    Molecules; 2020 Oct; 25(21):. PubMed ID: 33113776
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Delta-9-Tetrahydrocannabinol, Cannabidiol, and Acute Psychotomimetic States: A Balancing Act of the Principal Phyto-Cannabinoids on Human Brain and Behavior.
    Ganesh S; Cortes-Briones J; Schnakenberg Martin AM; Skosnik PD; D'Souza DC; Ranganathan M
    Cannabis Cannabinoid Res; 2023 Oct; 8(5):846-856. PubMed ID: 35319274
    [No Abstract]   [Full Text] [Related]  

  • 35. Which biological and self-report measures of cannabis use predict cannabis dependency and acute psychotic-like effects?
    Curran HV; Hindocha C; Morgan CJA; Shaban N; Das RK; Freeman TP
    Psychol Med; 2019 Jul; 49(9):1574-1580. PubMed ID: 30176957
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Increased hippocampal engagement during learning as a marker of sensitivity to psychotomimetic effects of δ-9-THC.
    Bhattacharyya S; Sainsbury T; Allen P; Nosarti C; Atakan Z; Giampietro V; Brammer M; McGuire PK
    Psychol Med; 2018 Dec; 48(16):2748-2756. PubMed ID: 29502548
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Clinical and Preclinical Evidence for Functional Interactions of Cannabidiol and Δ
    Boggs DL; Nguyen JD; Morgenson D; Taffe MA; Ranganathan M
    Neuropsychopharmacology; 2018 Jan; 43(1):142-154. PubMed ID: 28875990
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Δ9-Tetrahydrocannabinol alone and combined with cannabidiol mitigate fear memory through reconsolidation disruption.
    Stern CA; Gazarini L; Vanvossen AC; Zuardi AW; Galve-Roperh I; Guimaraes FS; Takahashi RN; Bertoglio LJ
    Eur Neuropsychopharmacol; 2015 Jun; 25(6):958-65. PubMed ID: 25799920
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Acute effects of cannabinoids on addiction endophenotypes are moderated by genes encoding the CB1 receptor and FAAH enzyme.
    Hindocha C; Freeman TP; Schafer G; Gardner C; Bloomfield MAP; Bramon E; Morgan CJA; Curran HV
    Addict Biol; 2020 May; 25(3):e12762. PubMed ID: 31013550
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The Effects of Acute Cannabis With and Without Cannabidiol on Neural Reward Anticipation in Adults and Adolescents.
    Skumlien M; Freeman TP; Hall D; Mokrysz C; Wall MB; Ofori S; Petrilli K; Trinci K; Borissova A; Fernandez-Vinson N; Langley C; Sahakian BJ; Curran HV; Lawn W
    Biol Psychiatry Cogn Neurosci Neuroimaging; 2023 Feb; 8(2):219-229. PubMed ID: 36642667
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 30.